Federal Minister for National Health Services, Regulations and Coordination, Syed Mustafa Kamal, on Friday termed the Pakistan-China Business-to-Business (B2B) Investment Conference a “game changer” for the country’s pharmaceutical industry, noting agreements worth around $100 million were expected to be signed during the event.
Pakistan, China hold landmark Pharma B2B Conference; $100 million deals expected
ISLAMABAD, Jul 17 (APP): Federal Minister for National Health Services, Regulations and Coordination, Syed Mustafa Kamal, on Friday termed the Pakistan-China Business-to-Business (B2B) Investment Conference a “game changer” for the country’s pharmaceutical industry, noting agreements worth around $100 million were expected to be signed during the event.
Addressing a joint press conference with the Prime Minister’s Special Assistant on Industries and Production, Haroon Akhtar Khan, the minister said the conference marked a significant milestone for Pakistan’s pharmaceutical sector.
He said the B2B conference covered all six segments of the pharmaceutical industry and brought together 170 delegations representing different categories of the sector.
The minister underscored that the initiative was in line with Prime Minister Shehbaz Sharif’s vision of expanding Pakistan’s pharmaceutical exports and integrating the country into new international markets.
While talking about preparations of the conference, Mustafa Kamal said extensive consultations had been held over the past six weeks between Pakistan’s Ambassador to China Khalil Hashmi, the Drug Regulatory Authority of Pakistan (DRAP), and other stakeholders to ensure the conference’s success.
He appreciated Haroon Akhtar Khan for holding dozens of meetings during the past six weeks and said every aspect of the conference had been planned through close coordination between the Ministry of Health, DRAP and other relevant institutions.
The minister also acknowledged the Ministry of Information and Broadcasting for translating all documentary material into Chinese language to facilitate engagement with Chinese participants.
Describing the conference as a landmark initiative, Mustafa Kamal said it had projected Pakistan’s potential and positive image before the international business community.
He said technology transfer through enhanced Pakistan-China cooperation would enable the country to access new global pharmaceutical markets while creating employment opportunities and strengthening the local industry.
Mustafa Kamal thanked all stakeholders whose collective efforts made the conference possible and expressed confidence that it would open a new chapter of cooperation between Pakistan and China in the pharmaceutical sector.
